Piphillin statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Prediction-based taxonomic classification chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

Piphillin specifications


Unique identifier OMICS_19013
Name Piphillin
Interface Web user interface
Restrictions to use None
Input data An OTU abundance table and a representative sequence.
Input format CSV, FASTA
Computer skills Basic
Stability Stable
Maintained Yes


  • person_outline Todd DeSantis <>

Publication for Piphillin

Piphillin in publication

PMCID: 5814395
PMID: 29449565
DOI: 10.1038/s41467-018-02967-w

[…] function heatmap.2 in the gplots package in r., to examine whether function of bacterial communities from enzootic and epizootic metamorph populations differed, gene prediction was performed using piphillin. a sequence identity cut-off of 97% was used and sequences were assigned putative function using the kegg reference database (may 2017 release). beta diversity of kegg orthology (ko) […]

To access a full list of publications, you will need to upgrade to our premium service.

Piphillin institution(s)
Informatics Department, Second Genome Inc., South San Francisco, CA, USA; Bluestone Center for Clinical Research and the Department of Oral and Maxillofacial Surgery, New York University College of Dentistry, New York, NY, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; Research and External Scientific Innovation Department, Allergan PLC, Irvine, CA, USA
Piphillin funding source(s)
Supported in part by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CA131286, R21 CA163019) and the National Institute of Dental and Craniofacial Research (R01 DE019796); and in part by Second Genome Inc and Allergan PLC.

Piphillin reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Piphillin